These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
209 related articles for article (PubMed ID: 12025779)
21. [The efficiency of cytoflavin and ozonotherapy in complex treatment of the myasthenia]. Drozd OA; Efremov VV; Dudarev IV Zh Nevrol Psikhiatr Im S S Korsakova; 2013; 113(1):46-9. PubMed ID: 23528494 [No Abstract] [Full Text] [Related]
22. [Positive effect of cytoflavin on metabolic status changes in patients with burn disorder]. Polutova NV; Ostrovskiĭ NV; Romantsov MG; Chesnokova NP Eksp Klin Farmakol; 2011; 74(7):33-7. PubMed ID: 21894767 [TBL] [Abstract][Full Text] [Related]
23. [Treatment of alcohol addiction syndrome with cytoflavin]. Belov VG; Parfenov IuA; Okovityĭ SV Zh Nevrol Psikhiatr Im S S Korsakova; 2013; 113(6 Pt 2):54-7. PubMed ID: 23887469 [TBL] [Abstract][Full Text] [Related]
24. [Clinical and morphologic efficacy of a complex antioxidant and energy correction therapy of different duration in brain infarction: results of a multicenter randomized trial]. Rumyantsevа SA; Kovalenko AL; Silinа EV; Stupin VA; Kabaeva EN; Chichanovskaya LV; Nazarov MV; Tsukurova LA; Burenichev DV; Golikov KV; Salnikov MV; Belova LA; Mashin VV; Mazina NK; Zhilina EA; Kolotik-Kameneva OY; Sherman MA Zh Nevrol Psikhiatr Im S S Korsakova; 2015; 115(8):45-52. PubMed ID: 26356615 [TBL] [Abstract][Full Text] [Related]
25. [Efficacy of antioxidant energocorreсtion in brain infarction (results of a multicenter randomized trial)]. Rumyantseva SA; Silina EV; Chichanovskaya LV; Nazarov MV; Tsukurova LA; Kovalenko AL; Kabaeva EN; Stupin VA Zh Nevrol Psikhiatr Im S S Korsakova; 2014; 114(10):49-55. PubMed ID: 25591516 [TBL] [Abstract][Full Text] [Related]
26. [Effect of cytoflavin on the recovery of cognitive function after the cardiaс surgery with artificial blood circulation]. Kardash OF; Shestakova LG; Krachak DI; Chernookiĭ OG; Zasetskiĭ AE; Ostrovskiĭ IuP Zh Nevrol Psikhiatr Im S S Korsakova; 2011; 111(7):76-9. PubMed ID: 21947077 [No Abstract] [Full Text] [Related]
27. [An influence of cytoflavin on oxidative stress and activity of Na/K-ATPase of erythrocytes after brain trauma]. Deriugina AV; Shumilova AV Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(11):51-55. PubMed ID: 29265087 [TBL] [Abstract][Full Text] [Related]
28. [The use of cytoflavin in the complex treatment of patients with tick-borne encephalitis]. Selezneva AG; Petrova AG Zh Nevrol Psikhiatr Im S S Korsakova; 2012; 112(7):68-9. PubMed ID: 23011438 [No Abstract] [Full Text] [Related]
29. [Clinical efficacy of cytoflavin in the combined treatment of patients during acute phase of ischemic stroke]. Shestakov VV; Kosenkova NV; Kichigina EV; Larikova TN; Starikova NL Klin Med (Mosk); 2011; 89(1):38-40. PubMed ID: 21516764 [TBL] [Abstract][Full Text] [Related]
30. [The efficacy of quinazopyrine, preparation E and riboxin in experimental myocardial infarct]. Stets VR; Tishkin VS; Evdokimov EI Vrach Delo; 1989 Dec; (12):13-4. PubMed ID: 2483471 [TBL] [Abstract][Full Text] [Related]
31. [Performance evaluation of integrated cytoprotective therapy of different duration in patients with cerebral infarction]. Chichanovskaia LV; Tsukurova LA; Kovalenko AL; Nazarov MV; Lukin DI; Rumiantseva SA; Silina EV; Stupin VA; Nedorostkova TIu; Kabaeva EN; Eliseev EV Eksp Klin Farmakol; 2015; 78(1):21-6. PubMed ID: 25826870 [TBL] [Abstract][Full Text] [Related]
33. [Modern methods of energy homeostasis correction in elderly patients]. Rumiantseva SA; Silina EV; Tsukurova LA; Stupin VA; Chichanovskaia LV; Nazarov MV; Kovalenko AL; Kabaeva EN Adv Gerontol; 2014; 27(4):746-52. PubMed ID: 25946854 [TBL] [Abstract][Full Text] [Related]
34. [Cytoflavin in the complex treatment of neuroinfections in children]. Skripchenko NV; Egorova ES Zh Nevrol Psikhiatr Im S S Korsakova; 2011; 111(9):28-31. PubMed ID: 22027666 [TBL] [Abstract][Full Text] [Related]
35. [Antioxidant therapy in discirculatory encephalopathy]. Antipenko EA; Gustov AV Zh Nevrol Psikhiatr Im S S Korsakova; 2010; 110(7):53-5. PubMed ID: 21465819 [No Abstract] [Full Text] [Related]
36. [Cytoflavin in the detoxification of alcohol-dependent patients]. Minko AI; Linskiĭ IV; Kuz'minov VN; Samoĭlova ES; Goloshchapov VV; Artemchuk KA Zh Nevrol Psikhiatr Im S S Korsakova; 2013; 113(6):35-40. PubMed ID: 23887449 [TBL] [Abstract][Full Text] [Related]
37. [The influence of cytoflavin and cardioxipin on the indices of lipid peroxidation and antioxidant protection in the blood of rat with dyslipidemia]. Vodop'ianova OA; Moiseeva IIa; Rodina OP; Kustikova IN; Antropova NV Eksp Klin Farmakol; 2014; 77(6):27-9. PubMed ID: 25102732 [TBL] [Abstract][Full Text] [Related]
38. [Correction of bioenergetic processes in small intestine during experimental widespread purulent peritonitis]. Kosinets VA Eksp Klin Farmakol; 2012; 75(8):39-43. PubMed ID: 23012995 [TBL] [Abstract][Full Text] [Related]
39. [The mechanism of action of riboxin]. Dunaev VV; Tishkin VS; Evdokimov EI; Belaĭ IM Farmakol Toksikol; 1989; 52(6):56-8. PubMed ID: 2483141 [TBL] [Abstract][Full Text] [Related]
40. [The efficacy of cytoflavin in the treatment of burnout syndrome]. Chutko LS; Surushkina SY; Yakovenko EA; Rozhkova AV; Anisimova TI; Bondarchuk YL Zh Nevrol Psikhiatr Im S S Korsakova; 2015; 115(10):66-70. PubMed ID: 26525625 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]